Home › Companies › Twist Bioscience Corporation › 2025-2026

Twist Bioscience Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Twist Bioscience Corporation’s Form 8-K, filed February 6, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

5Ballot items
275Asset managers
1,473Fund votes
February 5, 2026Meeting date

Results at a glance

Meeting of February 5, 2026: 5 items on Twist Bioscience Corporation’s Form 8-K, filed February 6, 2026: 2 approved · 3 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Twist Bioscience Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Twist Bioscience Corporation

These tallies are Twist Bioscience Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed February 6, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Twist Bioscience Corporation — official shareholder meeting results, meeting held February 5, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Keith Crandell	40,500,506	--	--	9,805,197	5,954,803	81%	Not verified	—
Elect Director: Jan Johannessen	42,319,597	--	--	7,986,106	5,954,803	84%	Not verified	—
Elect Director: Trynka Shineman Blake	50,217,493	--	--	88,210	5,954,803	99.8%	Not verified	—
2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")	38,430,673	11,842,367	32,663	--	5,954,803	76%	Approved	—
3. Ratification of Appointment of Independent Registered Accounting Firm	56,220,551	18,170	21,785	--	--	99.9%	Approved	—

Source: Twist Bioscience Corporation, Form 8-K, filed with the SEC on February 6, 2026 — read the filing on EDGAR.

How asset managers voted at the Twist Bioscience Corporation 2025-2026 meeting

Each item below shows how the 275 asset managers that disclosed a Twist Bioscience Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Jan Johannessen

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD

FOR: 42,319,597WITHHELD: 7,986,106

Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: Election of Class II Directors: Jan Johannessen

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Jan Johannessen”): 42,319,597 for, 7,986,106 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 18,709,055 for, 2,802,043 withheld, 261,295 abstained.

FOR

FOR: 18,709,055ABSTAIN: 261,295WITHHOLD: 2,802,043

Largest asset managers voting on “Election of Class II Directors: Jan Johannessen” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Abstain	Withheld	Vote
ARK ETF Trust	6,627,917	0	0	For
Vanguard	5,240,051	0	550	For
BlackRock	1,398,072	0	0	For
Thrivent	0	0	1,353,808	Withhold
WILLIAM BLAIR FUNDS	1,163,607	0	0	For
Invesco	799,105	0	0	For
Bridge Builder Trust	693,579	12,039	0	For
State Street	672,251	0	705	For
American Century	0	0	664,961	Withhold
Charles Schwab	546,571	0	0	For
Fidelity	289,094	0	0	For
TIAA	284,199	0	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	191,720	0	Abstain
Equitable	88,180	0	44,531	Mixed
AMERICAN BEACON FUNDS	132,163	0	0	For
Allspring	0	0	119,907	Withhold
Victory Capital	0	0	114,743	Withhold
MassMutual	103,125	0	0	For
AIG/SunAmerica	0	0	101,876	Withhold
QUANTITATIVE MASTER SERIES LLC	100,823	0	0	For
Direxion Shares ETF Trust	0	0	84,583	Withhold
Lincoln Financial	43,588	0	39,033	Mixed
OPTIMUM FUND TRUST	80,106	0	0	For
ARK Venture Fund	68,679	0	0	For
Neuberger Berman	66,754	0	0	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

2. Elect Director: Keith Crandell

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD

FOR: 40,500,506WITHHELD: 9,805,197

Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: Election of Class II Directors: Keith Crandell

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Keith Crandell”): 40,500,506 for, 9,805,197 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 17,756,438 for, 3,753,690 withheld, 262,265 abstained.

FORWITHHOLD

FOR: 17,756,438ABSTAIN: 262,265WITHHOLD: 3,753,690

Largest asset managers voting on “Election of Class II Directors: Keith Crandell” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Abstain	Withheld	Vote
ARK ETF Trust	6,627,917	0	0	For
Vanguard	5,240,051	0	550	For
BlackRock	1,398,072	0	0	For
Thrivent	0	0	1,353,808	Withhold
WILLIAM BLAIR FUNDS	1,163,607	0	0	For
Invesco	0	0	799,105	Withhold
Bridge Builder Trust	693,579	12,039	0	For
State Street	672,251	0	705	For
American Century	0	0	664,961	Withhold
Charles Schwab	546,571	0	0	For
Fidelity	289,094	0	0	For
TIAA	284,199	0	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	191,720	0	Abstain
Equitable	88,180	0	44,531	Mixed
AMERICAN BEACON FUNDS	132,163	0	0	For
Allspring	0	0	119,907	Withhold
Victory Capital	0	0	114,743	Withhold
MassMutual	0	0	103,125	Withhold
AIG/SunAmerica	0	0	101,876	Withhold
QUANTITATIVE MASTER SERIES LLC	100,823	0	0	For
Direxion Shares ETF Trust	0	0	84,583	Withhold
Lincoln Financial	43,588	0	39,033	Mixed
OPTIMUM FUND TRUST	80,106	0	0	For
ARK Venture Fund	68,679	0	0	For
Neuberger Berman	66,754	0	0	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

3. Elect Director: Trynka Shineman Blake

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 50,217,493WITHHELD: 88,210

Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: Election of Class II Directors: Trynka Shineman Blake

Twist Bioscience Corporation’s own tally for this item (“Elect Director: Trynka Shineman Blake”): 50,217,493 for, 88,210 withheld, per its Form 8-K filed February 6, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 21,762,989 for, 9,404 withheld.

FOR

FOR: 21,762,989WITHHOLD: 9,404

Largest asset managers voting on “Election of Class II Directors: Trynka Shineman Blake” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Vote
ARK ETF Trust	6,627,917	For
Vanguard	5,240,601	For
BlackRock	1,398,072	For
Thrivent	1,353,808	For
WILLIAM BLAIR FUNDS	1,163,607	For
Invesco	799,105	For
Bridge Builder Trust	705,618	For
State Street	672,956	For
American Century	664,961	For
Charles Schwab	546,571	For
Fidelity	289,094	For
TIAA	284,199	For
PROFESSIONALLY MANAGED PORTFOLIOS	191,720	For
Equitable	132,711	For
AMERICAN BEACON FUNDS	132,163	For
Allspring	119,907	For
Victory Capital	114,743	For
MassMutual	103,125	For
AIG/SunAmerica	101,876	For
QUANTITATIVE MASTER SERIES LLC	100,823	For
Direxion Shares ETF Trust	84,583	For
Lincoln Financial	82,621	For
OPTIMUM FUND TRUST	80,106	For
ARK Venture Fund	68,679	For
Neuberger Berman	66,754	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

4. 2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

76% Approved · of votes cast

FOR 76%AGAINST

FOR: 38,430,673AGAINST: 11,842,367

Details: description as filed, official tally, votes by 275 asset managers

Description as filed by funds: To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

Twist Bioscience Corporation’s own tally for this item (“2. Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs")”): 38,430,673 for, 11,842,367 against — passed, per its Form 8-K filed February 6, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Two — Non-Binding, Advisory Vote to Approve the Compensation of the Company's Named Executive Officers ("NEOs") The Company's stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of the Company's NEOs, by the following votes:”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 74 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Against	Vote
ARK ETF Trust	6,627,917	0	For
Vanguard	2,551,921	2,688,679	Mixed
BlackRock	1,398,072	0	For
Thrivent	0	1,353,808	Against
WILLIAM BLAIR FUNDS	1,163,607	0	For
Invesco	0	799,105	Against
Bridge Builder Trust	693,579	12,039	For
State Street	671,674	1,282	For
American Century	0	664,961	Against
Charles Schwab	546,571	0	For
Fidelity	289,094	0	For
TIAA	284,199	0	For
PROFESSIONALLY MANAGED PORTFOLIOS	0	191,720	Against
Equitable	88,180	44,531	Mixed
AMERICAN BEACON FUNDS	132,163	0	For
Allspring	0	119,907	Against
Victory Capital	0	114,743	Against
MassMutual	0	103,125	Against
AIG/SunAmerica	0	101,876	Against
QUANTITATIVE MASTER SERIES LLC	100,823	0	For
Direxion Shares ETF Trust	0	84,583	Against
Lincoln Financial	42,300	40,321	Mixed
OPTIMUM FUND TRUST	80,106	0	For
ARK Venture Fund	68,679	0	For
Neuberger Berman	66,754	0	For

Fund voting reports, all 74 managers: 15,075,475 for, 6,687,511 against, 9,404 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 217 asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Against	Vote
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	4,562,883	0	For
Artisan	4,219,930	0	For
Amova Asset Management Co., Ltd.	0	1,902,829	Against
BlackRock	1,810,887	20,016	For
Thrivent	0	1,361,830	Against
First Light Asset Management, LLC	1,131,281	0	For
Invesco	0	1,066,114	Against
BAILLIE GIFFORD & CO LTD	845,222	0	For
American Century	0	735,753	Against
Freshford Capital Management, LLC	616,475	0	For
State Street	558,216	8,266	For
Charles Schwab	546,982	0	For
Vanguard	447,281	58,677	Mixed
ARK Investment Management LLC	458,188	0	For
Soleus Capital Management, L.P.	398,064	0	For
JENNISON ASSOCIATES LLC	361,935	0	For
Aberdeen	308,116	0	For
Baillie Gifford Investment Management (Europe) Ltd	293,583	0	For
Nuveen	290,556	0	For
Northern Trust	263,272	12,677	For
GEODE CAPITAL MANAGEMENT, LLC	257,346	0	For
OSTERWEIS CAPITAL MANAGEMENT INC	0	254,798	Against
Wellington	248,097	0	For
JUPITER ASSET MANAGEMENT LTD	0	243,669	Against
PICTET ASSET MANAGEMENT SA	0	212,381	Against

Institutional-manager reports, all 217 managers: 19,030,498 for, 7,967,031 against, 85 abstained. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of Appointment of Independent Registered Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%

FOR: 56,220,551AGAINST: 18,170

Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2026.

Twist Bioscience Corporation’s own tally for this item (“3. Ratification of Appointment of Independent Registered Accounting Firm”): 56,220,551 for, 18,170 against — passed, per its Form 8-K filed February 6, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal Three — Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered accounting firm for the fiscal year ending September 30, 2026, by the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 21,762,989 for, 9,404 abstained.

FOR

FOR: 21,762,989ABSTAIN: 9,404

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FI” at Twist Bioscience Corporation, 2025-2026
Asset manager	For	Vote
ARK ETF Trust	6,627,917	For
Vanguard	5,240,601	For
BlackRock	1,398,072	For
Thrivent	1,353,808	For
WILLIAM BLAIR FUNDS	1,163,607	For
Invesco	799,105	For
Bridge Builder Trust	705,618	For
State Street	672,956	For
American Century	664,961	For
Charles Schwab	546,571	For
Fidelity	289,094	For
TIAA	284,199	For
PROFESSIONALLY MANAGED PORTFOLIOS	191,720	For
Equitable	132,711	For
AMERICAN BEACON FUNDS	132,163	For
Allspring	119,907	For
Victory Capital	114,743	For
MassMutual	103,125	For
AIG/SunAmerica	101,876	For
QUANTITATIVE MASTER SERIES LLC	100,823	For
Direxion Shares ETF Trust	84,583	For
Lincoln Financial	82,621	For
OPTIMUM FUND TRUST	80,106	For
ARK Venture Fund	68,679	For
Neuberger Berman	66,754	For

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.

Largest Twist Bioscience Corporation shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 61,311,704 shares outstanding at the time of that meeting.

Fund voting reports: top Twist Bioscience Corporation shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2025-2026
#	Asset manager	% of shares outstanding
1	ARK ETF Trust	10.81%
2	Vanguard	8.55%
3	BlackRock	2.28%
4	Thrivent	2.21%
5	WILLIAM BLAIR FUNDS	1.90%
6	Invesco	1.30%
7	Bridge Builder Trust	1.15%
8	State Street	1.10%
9	American Century	1.08%
10	Charles Schwab	0.89%

Institutional-manager reports: top Twist Bioscience Corporation shareholders by shares voted on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named…”, 2025-2026
#	Asset manager	% of shares outstanding
1	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	7.44%
2	Artisan	6.88%
3	Amova Asset Management Co., Ltd.	3.10%
4	BlackRock	2.99%
5	Thrivent	2.22%
6	First Light Asset Management, LLC	1.85%
7	Invesco	1.74%
8	BAILLIE GIFFORD & CO LTD	1.38%
9	American Century	1.20%
10	Freshford Capital Management, LLC	1.01%

Reported Twist Bioscience Corporation holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Twist Bioscience Corporation holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	9.42%	13F
BlackRock	9.06%	13F
Artisan Partners Asset Management Inc.	7.83%	13G
State Street	5.99%	13F
T. Rowe Price Associates, Inc.	5.93%	13G
ARK Investment Management LLC	5.52%	13G
EdgePoint Investment Group Inc.	4.11%	13G
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	3.55%	13G
Invesco	3.54%	13F
FMR (Fidelity)	3.08%	13F

Percentages above are of 61,311,704 shares outstanding, as reported by Twist Bioscience Corporation on its Form 10-Q dated January 27, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Twist Bioscience Corporation’s 10-Q dated January 27, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Twist Bioscience Corporation's shareholder meeting held February 5, 2026, in the 2025-2026 proxy season, 275 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,473 separate fund positions. On the most widely held item on that ballot — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — Twist Bioscience Corporation's filing reports the proposal as approved, with 76% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Twist Bioscience Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on February 6, 2026.

Twist Bioscience Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.